The resulting reduction in dopamine - a neurotransmitter that helps regulate movement - leads to the impaired motor control characteristic of Parkinson's.
As such, researchers have been investigating ways to block a-synuclein accumulation as a strategy to prevent Parkinson's or slow its progression.